allergy specialist Cincinnati oh

David I. Bernstein FAAAAI, FACAAI, FACP, M.D.

David I. Bernstein FAAAAI, FACAAI, FACP, M.D.

Board-Certified: American Board of Allergy & Immunology (participating in maintenance of certification), American Board of Internal Medicine, Diagnostic Laboratory Immunology.
Fellow: American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma & Immunology, American College of Physicians
Allergy Subspecialty Training: Adult & Pediatric Allergy & Clinical Immunology, Northwestern University Medical Center
Residency: Internal Medicine, Cleveland Clinic Hospital
Medical School: University of Cincinnati College of Medicine

Current Positions:

Professor: Department of Medicine and Environmental Health – Division of Immunology, Allergy and Rheumatology University of Cincinnati (1982 to Present)
Bernstein Clinical Research Center, LLC: Principal Investigator (1982 to Present)

Professional Activities:

– Board of Regents, American College of Allergy, Asthma & Immunology (2009 – present)
– American Board of Allergy Immunology (national certifying organization for allergists)
– Co-Director Allergy Fellowship Training Program (University of Cincinnati)
– Member, Joint Task Force for Practice Parameters in Allergy
– Honors: Best Doctor in Allergy and Immunology for the past 11 years Alpha Omega Alpha honorary medical society

Recent publications

  1. Bernstein DI, Tankersley M, Russell H. Injectable Epinephrine Should Be Prescribed to All Patients on Subcutaneous Aeroallergen Immunotherapy. J Allergy Clin Immunol Pract. 2020
  2. Schmidlin K, Sani S, Bernstein DI, Fonacier L. A Hands-on Approach to Contact Dermatitis and Patch Testing. J Allergy Clin Immunol Pract. 2020
  3. Bernstein DI, Epstein TEG. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy. Allergy Asthma Proc. 2020
  4. Nolte H, Bernstein DI, Nelson HS, Ellis AK, Kleine-Tebbe J, Lu S. Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial. J Allergy Clin Immunol Pract. 2020
  5. Bernstein DI, Pavord ID, Chapman KR, Follows R, Bentley JH, Pouliquen I, Bradford E. Usability of mepolizumab single-use prefilled autoinjector for patient self-administration. J Asthma. 2019
  6. Hassoun Y, Stevenson MR, Bernstein DI. Idiopathic Post-Prandial Diarrhea Responsive to Anti-histamines. Ann Allergy Asthma Immunol. 2019
  7. James C, Bernstein DI, Cox J, Ryan P, Wolfe C, Jandarov R, Newman N, Indugula R, Reponen T. HEPA filtration improves asthma control in children exposed to traffic-related airborne particles. Indoor Air. 2019
  8. Hassoun Y, James C, Bernstein DI. The Effects of Air Pollution on the Development of Atopic Disease. Clin Rev Allergy Immunol. 2019
  9. Mahler V, Esch RE, Kleine-Tebbe J, Lavery WJ, Plunkett G, Vieths S, Bernstein DI. Understanding differences in allergen immunotherapy products and practices in North America and Europe.235 J Allergy Clin Immunol. 2019
  10. Bernstein DI, Lummus ZL, Kesavalu B, Yao J, Kottyan L, Miller D, Cartier A, Cruz MJ, Lemiere C, Muñoz X, Quirce S, Tarlo S, Sastre J, Boulet LP, Weirauch MT, Kaufman K. Genetic variants with gene regulatory effects are associated with diisocyanate-induced asthma. J Allergy Clin Immunol. 2018
  11. Bernstein DI, Andersen L, Forth R, Jacques L, Yates L.Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA. J Asthma. 2018

4665 East Galbraith Rd 2nd floor Cincinnati, OH 45236

Call Us Now

Call Us Now

513-931-0775

Book Online

Book Online

Appointment Now